-
Highlights of the safety committee: December 2023
Highlights of the safety committee: December 2023
-
Highlights of the safety committee: December 2023
Highlights of the safety committee: December 2023
At its monthly meeting, the PRAC recommended measures for medicines containing pseudoephedrine and agreed to request further evidence in the GLP-1 receptor agonists’ review.
-
COVID-19 public health emergency: lessons learned
COVID-19 public health emergency: lessons learned
-
COVID-19 public health emergency: lessons learned
COVID-19 public health emergency: lessons learned
EMA and the Heads of Medicines Agencies review their response to COVID-19 and highlight key learnings in a joint report.
-
Call for patient representatives to join COMP
Call for patient representatives to join COMP
-
Call for patient representatives to join COMP
Call for patient representatives to join COMP
The European Commission has launched a call for expressions of interest to represent patients’ organisations in EMA's Committee for Orphan Medicinal Products
-
Looking for scientific experts to work with PRAC
Looking for scientific experts to work with PRAC
-
Looking for scientific experts to work with PRAC
Looking for scientific experts to work with PRAC
The European Commission is running a selection procedure to appoint six independent scientific experts to EMA’s safety committee
Information for you
Key content
Services & databases
-
List item
Clinical Trials website
-
List item
Account Management portal
-
List item
eSubmission
-
List item
EudraVigilance (human)
-
List item
EudraVigilance Veterinary
-
List item
Veterinary Medicines information website
-
List item
Suspected adverse drug reactions database
-
List item
Clinical data
-
List item
SPOR data management services
-
List item
Service Desk
-
List item
IRIS platform
-
List item
Public register of parallel distribution notices
-
List item
European Vaccination Information Portal